Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gnomestar Craft Inc VDQSF

Gnomestar Craft Inc. is a Canada-based craft cannabis company. The Company is engaged in the medical and recreational marijuana business. It operates in one business segment, the marijuana industry. The Company produces hand trimmed cultivars in its 12,000 square foot indoor facility in Delta, British Columbia.


GREY:VDQSF - Post by User

Comment by Griffin60on Jan 14, 2019 1:47pm
70 Views
Post# 29228887

RE:RE:RE:RE:RE:RE:RE:Anyone out there?

RE:RE:RE:RE:RE:RE:RE:Anyone out there?July 25, 2018, Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE: VP, FSE: 1JV1) (“Vodis” or the “Company”) is pleased to report that the Company has entered the Confirmation of Readiness stage to become a licenced producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) at its Delta, BC, facility. The Confirmation of Readiness stage is the final stage before obtaining a licence from Health Canada to cultivate cannabis under the ACMPR.

March 21, 2018, Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE:VP, FWB:1JV1) (“Vodis” or the “Company”) provides an update on operations in Canada and the United States. Since the fall of 2017, the Company’s Canadian operations have met the challenges of working capital requirements while it navigated the Health Canada licensing approval process. Vodis is pleased to report that all key personnel being the ‘Senior Person in Charge’, the ‘Responsible Person in Charge’, the ‘Alternate Responsible Person in Charge’ have now passed regulatory security clearance. Under the Access to Cannabis for Medical Purposes Regulations (ACMPR), key personnel ‘in charge’ must receive security clearance before a cultivation licence can be granted by Health Canada. Upon receiving confirmation of the security clearances, the Company responded to a comprehensive questionnaire from Health Canada on its standard operating procedures and detailed physical security protocols.


September 21st, 2017, Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV1) (“Vodis” or the “Company”) is pleased to inform investors that it is among the set of applicants to have recently been contacted by Health Canada. The Company’s application to produce cannabis under the ‘Access to Cannabis for Medical Purposes Regulations’ (ACMPR) in Canada is currently in ‘Active Review’.

Of course on October 23 2014 they released that they would be HC compliant by the end of November 2014.

Saintlyface wrote: The application process is more than just filling out the application and getting approved. It takes a lot of time. Also, they are in the final phases of this process. They received confirmation of readiness months back. They have moved on to submitting the evidence package. Next, they will be issued the license to cultivate. After this, they need to submit a full harvest for inspection. Then they can start selling to the public.
Griffin60 wrote: I have been concerned with the HC application claims from Vodis for some time. I have found their communications on the subject to be misleading.

trimmer3098 wrote:
No reason to lie at all. I bought this stock because I was assured the package was in, was under review a year ago. Just want you people to know. You decide what to do with the info. 
 

Soy Garipoglu soy.garipoglu@vodis.ca

Mon, Jan 29, 2018, 2:54 PM
 
 
to me
 
 
 
 
 
Hi, 
 
The management has advised me that our application is in good standing and is in active review with Health Canada. This is all that I can disclose at this time.
 
Thanks, 

Kind regards, 
 
Soy Garipoglu
 
Investor Relations
Vodis Pharmaceuticals Inc
Contact: 778-990-8985

 




<< Previous
Bullboard Posts
Next >>